Why Does Quantum Computing Stock Keep Going Up?

The U.S. Department of Commerce awarded $2 billion in quantum computing grants to nine companies, but Quantum Computing Inc. received $0. The article argues this is negative for QUBT because it is burning more than $42 million per year and would have benefited materially from a $100 million grant. Despite that, the stock had already risen 44% in three days, reflecting speculative momentum rather than fundamentals.

Analysis

The market is treating this like a broad “quantum” beta trade, but the real dispersion is between subsidized scale players and cash-burning story stocks. Grants to the better-capitalized winners lower their funding risk and de-rate the probability of forced equity issuance, which should tighten spreads between the funded names and the speculative names over the next 1-3 quarters. The absence of QUBT from the list is especially important because it removes the cleanest near-term dilution offset narrative that had been available to bulls.

For QUBT, the problem is not just missed revenue; it is financing optics. In a market willing to pay for optionality, the key second-order effect is that every rally improves management’s ability to raise capital, but also increases the probability that any future financing comes at a much richer valuation than fundamentals justify. That creates a fragile setup: the stock can stay elevated for days, but without a contract or grant catalyst, the trade is structurally dependent on momentum and retail attention rather than balance-sheet improvement.

GFS and IBM are more interesting than the headline suggests because the grants likely function as validation for industrial infrastructure, not just quantum R&D. That tends to pull in follow-on budgets, procurement relationships, and partner activity over months, which is more durable than a one-day pop. QBTS and RGTI get some benefit from category repricing, but the market will likely distinguish between names with concrete federal support and those merely riding sentiment.

The contrarian view is that the move in QUBT may not fully reverse immediately because “not winning” can still be interpreted as “not yet selected” by momentum traders. Still, once the initial narrative phase ends, fundamentals should matter more than category sympathy, and that argues for fading the weakest balance sheet in the group rather than shorting the strongest funded winners.

Key Decisions for Investors

• Short QUBT on strength over the next 1-5 trading days; use tight risk control above the recent squeeze high. Thesis: the stock is trading on category sympathy while lacking the balance-sheet and federal validation that should anchor the group.
• Long GFS / short QUBT pair for 1-3 months. Target a normalization in relative valuation as the market prices grant-backed execution risk lower for GFS while QUBT remains finance-dependent.
• Add to IBM on pullbacks over the next 2-6 weeks. The payoff is lower-beta but more durable: federal support should improve enterprise credibility and increase the odds of follow-on ecosystem wins.
• Speculative long QBTS or RGTI only as a momentum trade, not a fundamentals trade, and size it small. Best entry is after an intraday flush; risk/reward is favorable only if retail flows remain active for several sessions.
• If long QUBT is already held, buy short-dated puts or collar the position into the next 2-4 weeks. The main risk is a sentiment overshoot before fundamentals reassert, so protection is cheaper while implied volatility is still elevated.